Viewray Inc (NASDAQ:VRAY)’s stock price traded down 5.7% during mid-day trading on Tuesday . The stock traded as low as $3.04 and last traded at $3.12, 3,376,077 shares were traded during mid-day trading. An increase of 3% from the average session volume of 3,287,491 shares. The stock had previously closed at $3.31.
A number of research analysts have recently commented on VRAY shares. B. Riley reissued a “neutral” rating and set a $5.00 price target (down from $9.00) on shares of Viewray in a report on Wednesday, December 4th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Viewray in a report on Wednesday, November 13th. Zacks Investment Research downgraded shares of Viewray from a “buy” rating to a “hold” rating in a report on Tuesday. Mizuho reiterated a “buy” rating and issued a $9.00 target price on shares of Viewray in a research report on Tuesday, December 10th. Finally, ValuEngine raised shares of Viewray from a “hold” rating to a “buy” rating in a research note on Tuesday, December 3rd. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Viewray presently has a consensus rating of “Buy” and an average target price of $6.18.
The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.58 and a current ratio of 3.70. The stock has a 50 day moving average price of $3.22 and a 200 day moving average price of $3.41. The company has a market cap of $310.15 million, a P/E ratio of -3.00 and a beta of 1.23.
About Viewray (NASDAQ:VRAY)
ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.
Further Reading: What is a stock buyback?
Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.